Great Lakes Clinical Trials is proud to share in the announcement of the FDA’s approval of Lundbeck’s Vyepti™ – the first and only intravenous preventive treatment for migraines.
“We are pleased to see this important advancement of medicine, and improvement in our nation’s healthcare as a result of the important work we are doing at Great Lakes Clinical Trials,” commented Steve Satek, President of Great Lakes Clinical Trials. “First and foremost, we recognize and acknowledge the sincere commitment and dedication of our amazing volunteers who participated in this research. Without the contributions of our Chicagoland community in joining clinical trials, we would not have such important advances in our healthcare.”
Full Press Release
To review the full press release from Lundback, click here
About Migraines
Migraines are a complex and incapacitating neurological disease characterized by recurrent episodes of severe headaches typically accompanied by an array of symptoms, including nausea, vomiting, and sensitivity to light or sound. It is estimated to affect approximately 39 million people in the U.S. and more than 1.3 billion worldwide. Migraines have a profound impact on patients’ lives, their relationships, as well as their ability to carry out activities of daily living. More than 157 million work days are lost each year in the U.S. due to migraine
About Great Lakes Clinical Trials
Great Lakes Clinical Trials is an independent, phase I-IV clinical trials center, specializing in the study of investigational medications, food products, devices and supplements for the treatment of chronic diseases, notably in Mental Health, Memory Disorders, Pain Management, Vaccines, Nutrition and Dermatology. All medical services at Great Lakes Clinical Trials are provided free-of-charge, and are led by board-certified physicians. We do not bill insurance and health information is kept confidential, unless you ask us to collaborate with your personal physician. Stipends are provided for your participation - amounts vary based on each study. Free transportation is also provided for some of our trials. The Great Lakes team have managed more than 450 clinical trials over the past 25 years and are committed to providing quality services for both study volunteers & the research industry.